Evidence map›Paper›PMID 36678498›Full record

ReviewPharmaceuticals (Basel, Switzerland)2022

The Role of Zinc and NMDA Receptors in Autism Spectrum Disorders.

Kevin Lee, Zoe Mills, Pangying Cheung, Juliette E Cheyne, Johanna M Montgomery

Open access · goldAbstract readReview
In one paragraph

Review in Pharmaceuticals (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Perturbations of Zinc Homeostasis and Onset of Neuropsychiatric Disorders.International journal of molecular sciences · 2025
    Review
  11. Article
  12. Zinc in psychosis (Review).Molecular medicine reports · 2025
    Review
  13. Review
  14. Differential effectiveness of dietary zinc supplementation with autism-related behaviours inPhilosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024
    Article
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kevin LeeDepartment of Physiology and Centre for Brain Research, University of Auckland, Auckland 1010, New Zealand.
Zoe MillsDepartment of Physiology and Centre for Brain Research, University of Auckland, Auckland 1010, New Zealand.
Pangying CheungDepartment of Physiology and Centre for Brain Research, University of Auckland, Auckland 1010, New Zealand.
Juliette E CheyneDepartment of Physiology and Centre for Brain Research, University of Auckland, Auckland 1010, New Zealand.
Johanna M MontgomeryDepartment of Physiology and Centre for Brain Research, University of Auckland, Auckland 1010, New Zealand.ORCID 0000-0002-8714-7456
University of Auckland · NZ

Funding

Health Research Council of New Zealand 17_052
6 · The paper itself

Abstract

NMDA-type glutamate receptors are critical for synaptic plasticity in the central nervous system. Their unique properties and age-dependent arrangement of subunit types underpin their role as a coincidence detector of pre- and postsynaptic activity during brain development and maturation. NMDAR function is highly modulated by zinc, which is co-released with glutamate and concentrates in postsynaptic spines. Both NMDARs and zinc have been strongly linked to autism spectrum disorders (ASDs), suggesting that NMDARs are an important player in the beneficial effects observed with zinc in both animal models and children with ASDs. Significant evidence is emerging that these beneficial effects occur via zinc-dependent regulation of SHANK proteins, which form the backbone of the postsynaptic density. For example, dietary zinc supplementation enhances SHANK2 or SHANK3 synaptic recruitment and rescues NMDAR deficits and hypofunction in

Indexed as

autism spectrum disorderglutamateNMDA receptorsynaptic plasticityzinc

Identifiers

PMID36678498
PMCPMC9866730
OpenAlexW4312078617

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.